Gallbladder sepsis after stent insertion for bile duct obstruction: Management by percutaneous cholecystostomy
| Autor: | A. R. W. Hatfield, A. C. Smith, William R. Lees, S. J. Williams, R. C. G. Russell, C. C. Ainley |
|---|---|
| Rok vydání: | 1991 |
| Předmět: |
Male
medicine.medical_specialty Adenoma Gallbladder Stone Malignancy Sepsis Adenoma Bile Duct Postoperative Complications Cholecystitis medicine Carcinoma Humans Cholecystostomy Aged Cholestasis Bile duct business.industry Gallbladder Middle Aged medicine.disease Surgery Pancreatic Neoplasms medicine.anatomical_structure Bile Duct Neoplasms Female Stents business Complication |
| Zdroj: | British Journal of Surgery. 78:961-963 |
| ISSN: | 1365-2168 0007-1323 |
| DOI: | 10.1002/bjs.1800780822 |
| Popis: | Of 364 patients undergoing insertion of a biliary endoprosthesis in 1989, six (1·6 per cent) developed gallbladder sepsis. Three patients had cholangiocarcinoma, two had carcinoma of the pancreas and one had a benign biliary stricture. Two of the five patients with malignancy had gallbladder stones, and the patient with a benign stricture developed stones after 3 years of stenting. Three patients developed gallbladder sepsis early after endoprosthesis insertion (< 6 days), while in the other three it occurred late (> 6 months). All six patients failed to respond to antibiotics and were successfully managed by percutaneous cholecystostomy; the patient with a benign biliary stricture also had cholecystolithotomy. The gallbladder drainage tubes were removed or became dislodged at intervals varying from 2 weeks to 6 months without complications. Percutaneous cholecystostomy is the treatment of choice for gallbladder sepsis unresponsive to antibiotics in patients with a biliary endoprosthesis in situ. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text